Celltrion's 4-hormone obesity drug beats Lilly's retatrutide on weight loss in rat study

Coverage, in order

1. 7d ago
   Korea Biomedical Review South Korea obscure study in animals

   Celltrion's 4-hormone obesity drug beats Lilly's retatrutide on weight loss in rat study

   Celltrion's experimental obesity drug targeting four hormonal pathways produced greater weight loss than Eli Lilly's triple-acting retatrutide in a rat study, the Korean biopharmaceutical company said Wednesday.The candidate, CT-G32/SCO-940, simultaneously targets glucagon-like peptide-1 (GLP-1), gl

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.